IRCT2013011912175N1已完成3 期
The Effect of add on therapy of ultra-high dilution Natrium muriaticum on Depression and Quality of Life of depressed patients in comparison with placebo
Isfahan university of Medical sciences, Vice chancellor for research0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 37 years 至 65 years（—）
- 性别
- Male
入选标准
- •Age between 18 and 65.
- •Depress patients.
- •Do not have history of drug anaphylaxis.
- •Do not have psychosis.
- •Do not suffer from neurological or rheumatic treatment such as Multiple Sclerosis (MS), Vasculitis etc.
- •Do not have cancer nor receive chemotherapy
- •Match their symptoms with core dynamism of Natrium muriaticum
- •Not receive alternative medicine such as herbal medicine and acupuncture in the last month
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
The effect of intensive urate lowering therapy (ULT) with febuxostat in comparison with allopurinol on cardiovascular risk in patients with gout (short title: the FORWARD trial)EUCTR2014-005567-33-ITA. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.182
进行中（未招募）
1 期
The effect of intensive urate lowering therapy (ULT) with febuxostat in comparison with allopurinol on cardiovascular risk in patients with gout (short title: the FORWARD trial)GoutMedDRA version: 19.0Level: PTClassification code 10018627Term: GoutSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-005567-33-DEMenarini International Operations Luxembourg S.A.182
进行中（未招募）
1 期
The effect of intensive urate lowering therapy (ULT) with febuxostat in comparison with allopurinol on cardiovascular risk in patients with gout (short title: the FORWARD trial)GoutMedDRA version: 20.0Level: PTClassification code 10018627Term: GoutSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-005567-33-PLMenarini International Operations Luxembourg S.A.182
进行中（未招募）
1 期
The effect of intensive urate lowering therapy (ULT) with febuxostat in comparison with allopurinol on cardiovascular risk in patients with gout (short title: the FORWARD trial)EUCTR2014-005567-33-NLMenarini International Operations Luxembourg S.A.196
进行中（未招募）
1 期
The effect of intensive urate lowering therapy (ULT) with febuxostat in comparison with allopurinol on cardiovascular risk in patients with gout (short title: the FORWARD trial)GoutMedDRA version: 19.0 Level: PT Classification code 10018627 Term: Gout System Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-005567-33-HRMenarini International Operations Luxembourg S.A.196